Thursday, December 4 2025
8:00 am Registration & Welcome Coffee
8:50 am Chair’s Opening Remarks
R&D Innovations that can Enhance Performance, Minimize Operating Costs, & Accelerate Timelines
9:00 am Leveraging Genetic Modifications and Aggregate Culture to More Effectively Scale Cultivated Meat
Synopsis
- Using editing to alleviate cellular metabolic bottlenecks, reduce reliance on costly growth factors, and optimize cell proliferation in media.
- Cultivating cells in controlled aggregates—without dissociation steps—allowing for higher cell densities and reduced manufacturing complexity.
- Combining cell line engineering and alternative media components to enable more viable scale-up and regulatory-aligned commercialization.
9:30 am Cost and Production Volume Analysis of Amino Acids for Cultivated Meat
Synopsis
- Estimating the quantity of individual amino acids needed for a scaled cultivated meat industry.
- Analyzing the anticipated cost contribution for amino acids in cultivated meat production.
- Identifying amino acids that drive cost, those at risk of supply constraints, and alternative sourcing strategies using protein hydrolysates.
10:00 am Morning Networking Break
Synopsis
Meet and connect with your peers in this dedicated networking session
11:00 am Leveraging Metabolomic Profiling to Enable Scalable In-Suspension Cell Lines
Synopsis
- Understanding metabolomic data to map active metabolic pathways during expansion and differentiation phases.
- Identifying key shifts in suspension cultures to allow for differentiation and growth without aggregation or scaffolding.
- Applying insights from metabolic behaviour to streamline differentiation at scale.
What Investors Need to Hear & How to Deliver It: Understanding the Current Investment Climate & Setting Realistic Milestones
11:30 am Redefining Industry Milestones: Aligning Science & Business for Commercial Success
Synopsis
- Reassessing what “milestone progress” looks like for investors, operators, and partners in a largely post B2C era & as the number of post-approval pre-commercial companies rapidly increases.
- Linking internal technical advancement, regulatory progress, & B2B partnerships with market credibility, valuation, and funding triggers.
12:00 pm Lunch Break
Synopsis
Take this chance to meet the expert speakers, connect with your peers and explore our exhibition hall to meet fresh and familiar faces or even your next partner!
1:00 pm Shifting Consumer Perceptions of Cultivated Meat in an Era of Distrust and Opportunity
Synopsis
- Revealing new consumer sentiment trend insights from a multi-year survey on cultivated, plant-based, and precision-fermentation products
- Navigating the growing interest amid policy pushback and rising skepticism toward “artificial” foods
- Translating consumer data into commercial strategy to align messaging and market position to increase product adoption
1:30 pm Panel Discussion: Investor Expectations in 2025: How the Capital Landscape Has Changed
Synopsis
- Understanding the rising cost of capital, investor risk tolerance, and implications for M&A activity.
- Bridging the valuation gap: aligning company positioning with investor expectations amid ongoing consolidation.
- Capital raising strategies in a decentralized, post-vertical integration environment shaped by industry roll-ups and strategic acquisitions.
2:30 pm Chair’s Closing Remarks
2:45 pm Program Director’s Closing Remarks & End of Summit
Synopsis
Oscar Baines
Program Director, Hanson Wade